L. I. Cortínez, B. J. Anderson, A Penna, L Olivares, H. R. Muñoz, N. H

Slides:



Advertisements
Similar presentations
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
Advertisements

S. Arenas-Lopez, H. Mulla, S. Manna, A. Durward, I. A. Murdoch, S. M
F. Ravenelle, P. Vachon, A. E. Rigby-Jones, J. R. Sneyd, D
Human factors in anaesthesia: lessons from aviation
M. Kokki, P. Välitalo, M. Kuusisto, V. P. Ranta, K. Raatikainen, H
Norepinephrine and ephedrine do not counteract the increase in cutaneous microcirculation induced by spinal anaesthesia  J.-P.H. Lecoq, J.-F. Brichant,
Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia  M Hara, K Masui, D.J. Eleveld,
Pharmacokinetic parameter sets of alfentanil revisited: optimal parameters for use in target controlled infusion and anaesthesia display systems  N Sigmond,
Why is the surgical high-risk patient still at risk?
C.-A. Ewaldsson, R.G. Hahn  British Journal of Anaesthesia 
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
Intravenous lidocaine infusion reduces bispectral index-guided requirements of propofol only during surgical stimulation†   G.A. Hans, S.M. Lauwick, A.
M. M. Sahinovic, D. J. Eleveld, T Miyabe-Nishiwaki, M. M. R. F
AnestAssist British Journal of Anaesthesia
Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children  N.J. Bouwmeester, B.J. Anderson, D Tibboel, N.H.G.
Repeat dosing of rocuronium 1
Pharmacokinetic and pharmacodynamic interactions in anaesthesia
Problems in obtaining sufficient anaesthesia with propofol and remifentanil: three cases, a test infusion, and a review  S. Bache, L. Stendell, N.V. Olsen,
Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass  X. Delavenne, E. Ollier, S. Chollet, F. Sandri,
Electrocardiographic changes during continuous intravenous application of bupivacaine in neonatal pigs  J Mauch, A.P.N. Kutter, C Madjdpour, N Spielmann,
A.R. Absalom, V. Mani, T. De Smet, M.M.R. F. Struys 
Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass  E Takizawa, H Hiraoka, D Takizawa,
I.V. acetaminophen pharmacokinetics in neonates after multiple doses
Pharmacokinetics of ropivacaine in patients with chronic renal failure
Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: performance of three.
GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers  J.F. McLeod, J.M. Leempoels, S.X.
Dose adjustment of anaesthetics in the morbidly obese
Pharmacokinetics of intranasal fentanyl in parturient
Dexmedetomidine pharmacodynamics in healthy volunteers: 2
Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial  K.J.S. Anand, B.J. Anderson, N.H.G.
Remifentanil–midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery†  A.E. Rigby-Jones, M.J. Priston, J.R.
Accuracy of non-invasive measurement of haemoglobin concentration by pulse co- oximetry during steady-state and dynamic conditions in liver surgery  J.J.
Preadmission statin use improves the outcome of less severe sepsis patients - a population-based propensity score matched cohort study  M.G. Lee, C.-C.
Evaluation of the effect of intravenous lidocaine on propofol requirements during total intravenous anaesthesia as measured by bispectral index†  F.R.
Population pharmacokinetics of nalbuphine after surgery in children
EEG-controlled closed-loop dosing of propofol in rats
Recent advances in intravenous anaesthesia
Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children  F. Bressolle, A. Rochette, S. Khier,
Dexmedetomidine pharmacokinetic–pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation  P.J. Colin,
Pharmacodynamic response modelling of arterial blood pressure in adult volunteers during propofol anaesthesia  C. Jeleazcov, M. Lavielle, J. Schüttler,
Population pharmacokinetics of ε-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery  P.A. Stricker, M.R. Gastonguay, D. Singh,
Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery  P.A. Stricker, A.F. Zuppa, J.E. Fiadjoe,
The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient 
Patient state index vs bispectral index as measures of the electroencephalographic effects of propofol  M Soehle, M Kuech, M Grube, S Wirz, S Kreuer,
Blood alcohol concentration and psychomotor effects
Bispectral index is related to the spread of spinal sensory block in patients with combined spinal and general anaesthesia  R Iida, K Iwasaki, J Kato,
Predictive performance of ‘Servin's formula’ during BIS®-guided propofol-remifentanil target-controlled infusion in morbidly obese patients  A. Albertin,
Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose–response relationship 
Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under.
Predictive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled.
Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers  A.R. Absalom,
Do old pharmacokinetic parameter estimates predict new data?
F.H. Engbers, N Sutcliffe, G Kenny, S Schraag 
Visual metaphors on anaesthesia monitors do not improve anaesthetists' performance in the operating theatre  K. van Amsterdam, F. Cnossen, A. Ballast,
J.H.P. Friesen  British Journal of Anaesthesia 
Remifentanil–sevoflurane interaction models of circulatory response to laryngoscopy and circulatory depression  S.S. Bi, C.H. Deng, T.Y. Zhou, Z. Guan,
Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery  C. Solomon,
Individual patient data analysis of tidal volumes used in three large randomized control trials involving patients with acute respiratory distress syndrome 
L Witt, W. A. Osthaus, T Lücke, B Jüttner, N Teich, S Jänisch, A. S
Self-citation in anaesthesia and critical care journals: introducing a flat tax  G Landoni, M Pieri, D Nicolotti, S Silvetti, P Landoni, P Silvani, M John,
T.G. Hansen, K.F. Ilett, S.I. Lim, C. Reid, L.P. Hackett, R. Bergesio 
N. Khalili-Mahani, C.H. Martini, E. Olofsen, A. Dahan, M. Niesters 
G.B. Drummond, B. Lafferty  British Journal of Anaesthesia 
Validity of the 6 min walk test in prediction of the anaerobic threshold before major non- cardiac surgery  R.C.F. Sinclair, A.M. Batterham, S. Davies,
Influence of preoperative cognitive status on propofol requirement to maintain hypnosis in the elderly  F.-Z. Laalou, M Egard, M Guillot, E Noll, G Taglang,
Population pharmacokinetic analysis of ropivacaine and its metabolite 2′,6′- pipecoloxylidide from pooled data in neonates, infants, and children  L. Aarons,
I.V. ropivacaine compared with lidocaine for the treatment of tinnitus
M.A. Tooley, C.L. Stapleton, G.L. Greenslade, C Prys-Roberts 
Effect of body mass index on the ED50 volume of bupivacaine 0
Analysis of pharmacodynamic interaction of sevoflurane and propofol on bispectral index during general anaesthesia using a response surface model  J.C.
Presentation transcript:

Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model  L.I. Cortínez, B.J. Anderson, A Penna, L Olivares, H.R. Muñoz, N.H.G. Holford, M.M.R.F. Struys, P Sepulveda  British Journal of Anaesthesia  Volume 105, Issue 4, Pages 448-456 (October 2010) DOI: 10.1093/bja/aeq195 Copyright © 2010 The Author(s) Terms and Conditions

Fig 1 PC-VPC for the index study. The dashed blue lines present the 5th and 95th percentiles and the solid orange line depicts the model predicted median. The shaded grey area is the 90% confidence interval for the prediction percentiles. The 90% prediction interval and median for prediction corrected observed data are shown as lines with closed circles. (a) The first 20 min and (b) from 20 to 200 min. British Journal of Anaesthesia 2010 105, 448-456DOI: (10.1093/bja/aeq195) Copyright © 2010 The Author(s) Terms and Conditions

Fig 2 PC-VPC for the pooled analysis. See Fig. 1 for legend. British Journal of Anaesthesia 2010 105, 448-456DOI: (10.1093/bja/aeq195) Copyright © 2010 The Author(s) Terms and Conditions

Fig 3 Population prediction corrected visual predictive checks. See Fig. 1 for legend. The 90% prediction interval from the pooled analysis encompasses time–concentration profiles from the index study. Dosing comprised propofol 2 mg kg−1 at 200 mg min−1. An infusion of 10 mg kg−1 h−1 was started at 5 min and ran for 5 min. This was then decreased to 8 mg kg−1 h−1 for 20 min. The infusion was further decreased to 6 mg kg−1 h−1 for the next 30 min before slowing to 4.8 mg kg−1 h−1 for 120 min. British Journal of Anaesthesia 2010 105, 448-456DOI: (10.1093/bja/aeq195) Copyright © 2010 The Author(s) Terms and Conditions

Fig 4 Simulated propofol infusion rates of different PK models to reach and maintain a plasma concentration of 3.0 µg ml−1. The simulated case is a 30 yr woman with a TBW of 140 kg and a height of 160 cm (BMI 54.7 kg m−2). British Journal of Anaesthesia 2010 105, 448-456DOI: (10.1093/bja/aeq195) Copyright © 2010 The Author(s) Terms and Conditions

Fig 5 Simulated propofol time–concentration profiles predicted by three different PK models after a 3 h infusion with a plasma target of 3.0 µg ml−1 The simulated case is a 30 yr woman with a TBW of 140 kg and a height of 160 cm (BMI 54.7 kg m−2). Marsh (TBW) and Marsh (weight-adjusted) are indistinguishable since rate constants in Marsh PK parameters are not influenced by weight. British Journal of Anaesthesia 2010 105, 448-456DOI: (10.1093/bja/aeq195) Copyright © 2010 The Author(s) Terms and Conditions